Cargando…
Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers
Cancer immunotherapy has achieved multiple clinical benefits and has become an indispensable component of cancer treatment. Targeting tumor-specific antigens, also known as neoantigens, plays a crucial role in cancer immunotherapy. T cells of adaptive immunity that recognize neoantigens, but do not...
Autores principales: | Pao, Shih-Cheng, Chu, Mu-Tzu, Hung, Shuen-Iu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029780/ https://www.ncbi.nlm.nih.gov/pubmed/35456701 http://dx.doi.org/10.3390/pharmaceutics14040867 |
Ejemplares similares
-
Recent Development and Clinical Application of Cancer Vaccine: Targeting Neoantigens
por: Pan, Ren-You, et al.
Publicado: (2018) -
Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators
por: Chu, Mu-Tzu, et al.
Publicado: (2023) -
Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies
por: Reynolds, Carson R., et al.
Publicado: (2022) -
Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
por: Repáraz, David, et al.
Publicado: (2022) -
The perfect personalized cancer therapy: cancer vaccines against neoantigens
por: Aurisicchio, Luigi, et al.
Publicado: (2018)